We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+1.76%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$21.4B
AUM Growth
+$1.5B
Cap. Flow
+$1.66B
Cap. Flow %
7.75%
Top 10 Hldgs %
50.4%
Holding
201
New
31
Increased
27
Reduced
32
Closed
37

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$1.41B
2
CHTR icon
Charter Communications
CHTR
+$462M
3
CBRE icon
CBRE Group
CBRE
+$375M
4
SGEN
Seagen Inc. Common Stock
SGEN
+$314M
5
VMW
VMware, Inc
VMW
+$285M

Top Sells

Rank Stock Value
1
EFX icon
Equifax
EFX
+$249M
2
IQV icon
IQVIA
IQV
+$239M
3
BIIB icon
Biogen
BIIB
+$172M
4
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$130M
5
TMO icon
Thermo Fisher Scientific
TMO
+$105M

Sector Composition

Rank Sector Weight
1 Healthcare 31.13%
2 Technology 23.99%
3 Financials 9.09%
4 Communication Services 6.05%
5 Industrials 4.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
THC icon
51
Tenet Healthcare
THC
$21.1B
$67.9M 0.32%
1,030,000
+278,000
+37% +$20.8M
SIMO icon
52
Silicon Motion
SIMO
$8.68B
$53.6M 0.25%
1,045,000
+110,000
+12% +$6.26M
EVH icon
53
Evolent Health
EVH
$447M
$51.8M 0.24%
1,900,909
– –
DXCM icon
54
DexCom
DXCM
$32B
$50.8M 0.24%
+544,000
New +$61.3M
NBIX icon
55
Neurocrine Biosciences
NBIX
$16.6B
$50.4M 0.24%
+448,000
New +$47.2M
ROIV icon
56
Roivant Sciences
ROIV
$26.2B
$45M 0.21%
3,853,400
+1,498,400
+64% +$16.9M
MRTX
57
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$43.6M 0.2%
+1,001,000
New +$35.7M
HCA icon
58
HCA Healthcare
HCA
$89.5B
$42.9M 0.2%
174,400
-88,000
-34% -$24.1M
DEN
59
DELISTED
Denbury Inc.
DEN
$41.7M 0.19%
+425,000
New +$38.5M
SVRA icon
60
Savara
SVRA
$1.19B
$41.2M 0.19%
10,908,086
– –
SPLK
61
DELISTED
Splunk Inc
SPLK
$39.7M 0.19%
+271,625
New +$30.8M
AMED
62
DELISTED
Amedisys
AMED
$39.6M 0.18%
+424,000
New +$39.2M
IONS icon
63
Ionis Pharmaceuticals
IONS
$9.4B
$33M 0.15%
727,000
+722,000
+14,440% +$29.8M
CRL icon
64
Charles River Laboratories
CRL
$12.8B
$28.6M 0.13%
+146,000
New +$30M
OPCH icon
65
Option Care Health
OPCH
$3.56B
$27.9M 0.13%
862,000
-1,205,134
-58% -$40.6M
ENTA icon
66
Enanta Pharmaceuticals
ENTA
$400M
$20.9M 0.1%
1,875,000
– –
X
67
DELISTED
US Steel
X
$20.6M 0.1%
+635,000
New +$17.8M
MASI
68
DELISTED
Masimo
MASI
$20M 0.09%
227,649
-140,000
-38% -$16.3M
BHVN icon
69
Biohaven
BHVN
$2.21B
$19.5M 0.09%
750,000
– –
IMVT icon
70
Immunovant
IMVT
$8.25B
$19.3M 0.09%
+504,000
New +$11.4M
SEDA
71
DELISTED
SDCL EDGE Acquisition Corporation
SEDA
$18.4M 0.09%
1,732,500
– –
NATI
72
DELISTED
National Instruments Corp
NATI
$15.8M 0.07%
+265,000
New +$15.6M
AAC
73
DELISTED
Ares Acquisition Corporation
AAC
$15.3M 0.07%
1,425,000
– –
ZYME icon
74
Zymeworks
ZYME
$1.67B
$12.7M 0.06%
2,000,000
– –
ESTE
75
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
$12.5M 0.06%
+618,831
New +$10.8M
1 2
3
4 5

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Farallon Capital Management held 201 positions worth $21.4B, up 7.5% from $19.9B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Farallon Capital Management deployed $1.66B of net new capital in Q3 2023, opening 31 new positions and adding to 27 existing holdings. Its largest new stake was Charter Communications: 1,111,341 shares worth $489M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 35% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was IQVIA, an estimated $239M trimmed.

  • Farallon Capital Management's largest Q3 2023 buy was Charter Communications: 1,111,341 shares worth $489M.
  • Farallon Capital Management added most to Activision Blizzard in Q3 2023, an estimated $1.41B increase.
  • Farallon Capital Management's biggest Q3 2023 reduction was IQVIA, cutting an estimated $239M.
  • Farallon Capital Management fully exited Equifax in Q3 2023, selling an estimated $249M.
  • Farallon Capital Management's ten largest holdings make up 50% of its $21.4B portfolio in Q3 2023.
  • Farallon Capital Management opened 31 new positions and closed 37 in Q3 2023.
  • Farallon Capital Management's portfolio value rose 7.5% quarter-over-quarter to $21.4B.

Based on Farallon Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.